1
项与 DNAJB1-PRKACA peptide vaccine(The Sidney Kimmel Comprehensive Cancer Center) 相关的临床试验A Pilot Study of a DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
The primary objective of the trial is the safety and tolerability of administering a vaccine targeting the DNAJB1-PRKACA fusion kinase, in combination with nivolumab and ipilimumab in patients with unresectable or metastatic FLC and with non-FLC solid tumors and to assess the T-cell response.
100 项与 DNAJB1-PRKACA peptide vaccine(The Sidney Kimmel Comprehensive Cancer Center) 相关的临床结果
100 项与 DNAJB1-PRKACA peptide vaccine(The Sidney Kimmel Comprehensive Cancer Center) 相关的转化医学
100 项与 DNAJB1-PRKACA peptide vaccine(The Sidney Kimmel Comprehensive Cancer Center) 相关的专利(医药)
100 项与 DNAJB1-PRKACA peptide vaccine(The Sidney Kimmel Comprehensive Cancer Center) 相关的药物交易